Abstract
It has been reported that most tumor cells show an increased uptake of variety of amino acids specially methionine when compared with normal cells and amino acid transport is generally increased in malignant transformation. Based on the evidences, two novel nanosized analogues of methionine (Anionic Linear Globular Dendrimer G2, a biodigredabale anionic linear globular-Methionin, and DTPA-Methionine1 conjugates) were synthesized and labeled with 99mTc and used in tumor imaging/ therapy in vitro and in vivo. The results showed marked tumor SPECT molecular imaging liabilities for both compounds but with a better performance by administration of 99mTc-Dendrimer G2-Methionin. The results also showed a good anticancer activity for 99mTc-DTPA-Methionine. Based on the present study 99mTc-Dendrimer G2-Methionin or 99mTc-DTPA-(Methionine)1 have potentials to be used in tumor molecular imaging as well as cancer therapy in future.
Keywords: Tumor cells, nanosized, methionine, DTPA, dendrimer G2, SPECT, amino acids, malignant transformation, nanosized analogues, globular-Methion
Current Medicinal Chemistry
Title:A Comparative Study of Two Novel Nanosized Radiolabeled Analogues of Methionine for SPECT Tumor Imaging
Volume: 20 Issue: 1
Author(s): A.G. Khosroshahi, M. Amanlou, O. Sabzevari, F.J. Daha, M.R. Aghasadeghi, M. Ghorbani, M.S. Ardestani, M.S. Alavidjeh, S.M. Sadat, M.H. Pouriayevali, L. Mousavi and S.E.S. Ebrahimi
Affiliation:
Keywords: Tumor cells, nanosized, methionine, DTPA, dendrimer G2, SPECT, amino acids, malignant transformation, nanosized analogues, globular-Methion
Abstract: It has been reported that most tumor cells show an increased uptake of variety of amino acids specially methionine when compared with normal cells and amino acid transport is generally increased in malignant transformation. Based on the evidences, two novel nanosized analogues of methionine (Anionic Linear Globular Dendrimer G2, a biodigredabale anionic linear globular-Methionin, and DTPA-Methionine1 conjugates) were synthesized and labeled with 99mTc and used in tumor imaging/ therapy in vitro and in vivo. The results showed marked tumor SPECT molecular imaging liabilities for both compounds but with a better performance by administration of 99mTc-Dendrimer G2-Methionin. The results also showed a good anticancer activity for 99mTc-DTPA-Methionine. Based on the present study 99mTc-Dendrimer G2-Methionin or 99mTc-DTPA-(Methionine)1 have potentials to be used in tumor molecular imaging as well as cancer therapy in future.
Export Options
About this article
Cite this article as:
Khosroshahi A.G., Amanlou M., Sabzevari O., Daha F.J., Aghasadeghi M.R., Ghorbani M., Ardestani M.S., Alavidjeh M.S., Sadat S.M., Pouriayevali M.H., Mousavi L. and Ebrahimi S.E.S., A Comparative Study of Two Novel Nanosized Radiolabeled Analogues of Methionine for SPECT Tumor Imaging, Current Medicinal Chemistry 2013; 20 (1) . https://dx.doi.org/10.2174/0929867311302010012
DOI https://dx.doi.org/10.2174/0929867311302010012 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
Current Medicinal Chemistry Resveratrol, a Phytochemical Inducer of Multiple Cell Death Pathways: Apoptosis, Autophagy and Mitotic Catastrophe
Current Medicinal Chemistry Aptamers: Selection, Modification and Application to Nervous System Diseases
Current Medicinal Chemistry 2-(ω-Carboxyethyl)pyrrole Antibody as a New Inhibitor of Tumor Angiogenesis and Growth
Anti-Cancer Agents in Medicinal Chemistry Pyruvate Kinase M2: Regulatory Circuits and Potential for Therapeutic Intervention
Current Pharmaceutical Design CEST MRI for Molecular Imaging of Brain Metabolites
Current Molecular Imaging (Discontinued) Proinflammatory Cytokines in Breast Cancer: Mechanisms of Action and Potential Targets for Therapeutics
Current Drug Targets Emerging Insights in the Role of Tissue Factor in Cancer
Current Genomics The Molecular Mechanisms of TRAIL Resistance in Cancer Cells: Help in Designing New Drugs
Current Pharmaceutical Design Direct Targeting of the Ras GTPase Superfamily Through Structure- Based Design
Current Topics in Medicinal Chemistry The Epithelial-Mesenchymal Transition and Cancer Stem Cells: Functional and Mechanistic Links
Current Pharmaceutical Design CSPG4 in Cancer: Multiple Roles
Current Molecular Medicine Target Driven Preclinical Screening for New Antimitotic Chemotherapy Agents
Current Topics in Medicinal Chemistry RNAi in Clinical Studies
Current Medicinal Chemistry Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway
Current Topics in Medicinal Chemistry CDK Inhibitors: From the Bench to Clinical Trials
Current Drug Targets Redox Regulation in the Base Excision Repair Pathway: Old and New Players as Cancer Therapeutic Targets
Current Medicinal Chemistry Manipulation of Intracellular pH in Cancer Cells by NHE1 Inhibitors
Protein & Peptide Letters Mechanisms of ERK1/2 Regulation by Seven-Transmembrane-Domain Receptors
Current Pharmaceutical Design Development and Clinical Application of Tumor-derived Exosomes in Patients with Cancer
Current Stem Cell Research & Therapy